Dr. Singh is working as Assistant Professor at Pachhunga University College (PUC) campus of Mizoram Central University, Mizoram, India. She has completed her doctorate in 2018 from Mizoram University, India in plant sciences and worked on the pharmaceutical potential of selected traditional medicinal plants. Dr. Singh has 8 years of research experience and has published several research papers in national and international journals having high impact factor like Scientific reports, BMC complementary and alternative medicine, frontiers in plant sciences, etc. Dr. Singh has awarded for her work by several agencies while presenting her research work in India and abroad. Her expertise lies in the areas of utilization of traditional medicinal plants for sustainable development, secondary metabolites extraction and documentation of traditional medicinal pants. Dr. Singh is running one externally funded project to explore the pharmaceutical potential of some selected traditional medicinal plants located in North East India.

• Section I: The ever-growing complexity of epigenetic regulation of gene expression1. Epigenetic regulation of gene expression: An overview of classical and recently discovered novel players: -Role of DNA methylation, Role of Histone modifications, Role of non-coding RNAs2. Epigenetic regulation of transposable elements and their impact on developmental processes3. Epigenetic regulation of germ cells4. Epigenetic regulation of cis-regulatory elements and transcription factors during development5. Genomic imprinting and developmental physiology: Intrauterine growth and postnatal period6. Metabolic regulation of epigenetic processes7. Role of RNA epigenetics in developmentSection II: Epigenetic programming of the placenta regulates short-term and long-term health outcomes8. Epigenetic regulation of placental function9. Role of placenta in developmental programming of sex-specific adult outcomes10. Epigenetic changes induced by Assisted Reproductive Technologies (ART) in the placenta and its effect on developmental outcomesSection III: Epigenetics, hormones, sex and developmental programming11. Epigenetic and hormone interaction and effect on gene regulation during prenatal and early postnatal life12. Role of epigenetics in shaping the sex difference in immune function during development13. Role of epigenetics in shaping sex differences in brain development and behavior14. Role of epigenetics in shaping sex differences in heart development and later life cardiovascular disease riskSection IV: Epigenetic programming by adverse perinatal influences15. Early life endocrine disruptors exposure and epigenetic programming16. Early life stress exposure and epigenetic programming17. Early life nutrition and epigenetic programming18. Early life air pollution exposure and epigenetic programming19. Early life substance abuse and epigenetic programmingSection V: Advancing translational epigenetic research21. Modelling early life adversity in the laboratory –: Animal models, their advantages and challenges in extrapolating findings from animal studies to humans22. Clinical evidence of developmental programming due to early life exposures and long-term effects: Implications for public health23. Phenotypic plasticity: Adaptive vs Maladaptive response and epigenetic changes24. Epigenomics: A road to genome-wide characterization of epigenetic changes during development and identifying future individuals at risk of disease susceptibilitySection VI: Pharmacological and non-pharmacological approaches to reprogram the developmental programming to improve the health outcomes26. Epigenetic signatures as biomarkers of early life experiences27. Environmental enrichment and its effect on modifying the epigenetic changes induced by early life adversity28. Dietary targeting of epigenome and its effect on early life adverse influences29. Early postnatal maternal care and epigenetic programming of HPA axis activity30. Emerging field of epigenetic editing: Implication for translational purposes for diseases with developmental origin and sex bias

Select Guide Rating

Dr. Singh is working as Assistant Professor at Pachhunga University College (PUC) campus of Mizoram Central University, Mizoram, India. She has completed her doctorate in 2018 from Mizoram University, India in plant sciences and worked on the pharmaceutical potential of selected traditional medicinal plants. Dr. Singh has 8 years of research experience and has published several research papers in national and international journals having high impact factor like Scientific reports, BMC complementary and alternative medicine, frontiers in plant sciences, etc. Dr. Singh has awarded for her work by several agencies while presenting her research work in India and abroad. Her expertise lies in the areas of utilization of traditional medicinal plants for sustainable development, secondary metabolites extraction and documentation of traditional medicinal pants. Dr. Singh is running one externally funded project to explore the pharmaceutical potential of some selected traditional medicinal plants located in North East India.

• Section I: The ever-growing complexity of epigenetic regulation of gene expression1. Epigenetic regulation of gene expression: An overview of classical and recently discovered novel players: -Role of DNA methylation, Role of Histone modifications, Role of non-coding RNAs2. Epigenetic regulation of transposable elements and their impact on developmental processes3. Epigenetic regulation of germ cells4. Epigenetic regulation of cis-regulatory elements and transcription factors during development5. Genomic imprinting and developmental physiology: Intrauterine growth and postnatal period6. Metabolic regulation of epigenetic processes7. Role of RNA epigenetics in developmentSection II: Epigenetic programming of the placenta regulates short-term and long-term health outcomes8. Epigenetic regulation of placental function9. Role of placenta in developmental programming of sex-specific adult outcomes10. Epigenetic changes induced by Assisted Reproductive Technologies (ART) in the placenta and its effect on developmental outcomesSection III: Epigenetics, hormones, sex and developmental programming11. Epigenetic and hormone interaction and effect on gene regulation during prenatal and early postnatal life12. Role of epigenetics in shaping the sex difference in immune function during development13. Role of epigenetics in shaping sex differences in brain development and behavior14. Role of epigenetics in shaping sex differences in heart development and later life cardiovascular disease riskSection IV: Epigenetic programming by adverse perinatal influences15. Early life endocrine disruptors exposure and epigenetic programming16. Early life stress exposure and epigenetic programming17. Early life nutrition and epigenetic programming18. Early life air pollution exposure and epigenetic programming19. Early life substance abuse and epigenetic programmingSection V: Advancing translational epigenetic research21. Modelling early life adversity in the laboratory –: Animal models, their advantages and challenges in extrapolating findings from animal studies to humans22. Clinical evidence of developmental programming due to early life exposures and long-term effects: Implications for public health23. Phenotypic plasticity: Adaptive vs Maladaptive response and epigenetic changes24. Epigenomics: A road to genome-wide characterization of epigenetic changes during development and identifying future individuals at risk of disease susceptibilitySection VI: Pharmacological and non-pharmacological approaches to reprogram the developmental programming to improve the health outcomes26. Epigenetic signatures as biomarkers of early life experiences27. Environmental enrichment and its effect on modifying the epigenetic changes induced by early life adversity28. Dietary targeting of epigenome and its effect on early life adverse influences29. Early postnatal maternal care and epigenetic programming of HPA axis activity30. Emerging field of epigenetic editing: Implication for translational purposes for diseases with developmental origin and sex bias

Select Guide Rating

Dr. Singh is working as Assistant Professor at Pachhunga University College (PUC) campus of Mizoram Central University, Mizoram, India. She has completed her doctorate in 2018 from Mizoram University, India in plant sciences and worked on the pharmaceutical potential of selected traditional medicinal plants. Dr. Singh has 8 years of research experience and has published several research papers in national and international journals having high impact factor like Scientific reports, BMC complementary and alternative medicine, frontiers in plant sciences, etc. Dr. Singh has awarded for her work by several agencies while presenting her research work in India and abroad. Her expertise lies in the areas of utilization of traditional medicinal plants for sustainable development, secondary metabolites extraction and documentation of traditional medicinal pants. Dr. Singh is running one externally funded project to explore the pharmaceutical potential of some selected traditional medicinal plants located in North East India.

• Section I: The ever-growing complexity of epigenetic regulation of gene expression1. Epigenetic regulation of gene expression: An overview of classical and recently discovered novel players: -Role of DNA methylation, Role of Histone modifications, Role of non-coding RNAs2. Epigenetic regulation of transposable elements and their impact on developmental processes3. Epigenetic regulation of germ cells4. Epigenetic regulation of cis-regulatory elements and transcription factors during development5. Genomic imprinting and developmental physiology: Intrauterine growth and postnatal period6. Metabolic regulation of epigenetic processes7. Role of RNA epigenetics in developmentSection II: Epigenetic programming of the placenta regulates short-term and long-term health outcomes8. Epigenetic regulation of placental function9. Role of placenta in developmental programming of sex-specific adult outcomes10. Epigenetic changes induced by Assisted Reproductive Technologies (ART) in the placenta and its effect on developmental outcomesSection III: Epigenetics, hormones, sex and developmental programming11. Epigenetic and hormone interaction and effect on gene regulation during prenatal and early postnatal life12. Role of epigenetics in shaping the sex difference in immune function during development13. Role of epigenetics in shaping sex differences in brain development and behavior14. Role of epigenetics in shaping sex differences in heart development and later life cardiovascular disease riskSection IV: Epigenetic programming by adverse perinatal influences15. Early life endocrine disruptors exposure and epigenetic programming16. Early life stress exposure and epigenetic programming17. Early life nutrition and epigenetic programming18. Early life air pollution exposure and epigenetic programming19. Early life substance abuse and epigenetic programmingSection V: Advancing translational epigenetic research21. Modelling early life adversity in the laboratory –: Animal models, their advantages and challenges in extrapolating findings from animal studies to humans22. Clinical evidence of developmental programming due to early life exposures and long-term effects: Implications for public health23. Phenotypic plasticity: Adaptive vs Maladaptive response and epigenetic changes24. Epigenomics: A road to genome-wide characterization of epigenetic changes during development and identifying future individuals at risk of disease susceptibilitySection VI: Pharmacological and non-pharmacological approaches to reprogram the developmental programming to improve the health outcomes26. Epigenetic signatures as biomarkers of early life experiences27. Environmental enrichment and its effect on modifying the epigenetic changes induced by early life adversity28. Dietary targeting of epigenome and its effect on early life adverse influences29. Early postnatal maternal care and epigenetic programming of HPA axis activity30. Emerging field of epigenetic editing: Implication for translational purposes for diseases with developmental origin and sex bias

Select Guide Rating